| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 67,044 | 02 Mar 2026 | Direct | ||
| Eikon Therapeutics, Inc. | Chief Financial Officer | Common Stock | 51,572 | 04 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EIKN | Eikon Therapeutics, Inc. | 02 Mar 2026 | 1 | $0 | 4 | Chief Financial Officer | 04 Mar 2026, 16:58 |
| EIKN | Eikon Therapeutics, Inc. | 04 Feb 2026 | 0 | $0 | 3 | Chief Financial Officer | 04 Feb 2026, 21:34 |